Imaging of compensatory mechanisms in Parkinson's disease

被引:72
作者
Appel-Cresswell, Silke [1 ,2 ]
de la Fuente-Fernandez, Raul [1 ,2 ]
Galley, Shawna [1 ]
McKeown, Martin J. [1 ,2 ]
机构
[1] Univ British Columbia, Pacific Parkinsons Res Ctr, Vancouver, BC V6T 2B5, Canada
[2] Univ British Columbia, Dept Med Neurol, Vancouver, BC V6T 2B5, Canada
关键词
compensation; connectivity; functional MRI; imaging; Parkinson's disease; PET; POSITRON-EMISSION-TOMOGRAPHY; METABOLIC NETWORK ACTIVITY; IN-VIVO; L-DOPA; C-11; RACLOPRIDE; CONNECTIVITY; MOVEMENTS; BINDING; PET; DYSFUNCTION;
D O I
10.1097/WCO.0b013e32833b6019
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose of review The on-going quest for potentially disease-modifying therapies in Parkinson's disease has prompted the development of methods that can differentiate direct disease effects from compensatory processes. Recent findings PET studies have suggested a number of changes at the synaptic level to maintain integrity of dopaminergic systems. Functional MRI studies support the long-held belief that relatively intact cerebellar circuits may compensate for impaired basal ganglia function. Altered connectivity and increased spatial extent of activation also appear to be mechanisms through which motor and cognitive performance can be maintained. Summary Ascertaining which changes in brain activation in Parkinson's disease are, in fact, compensatory represents a serious challenge. Compensatory mechanisms have been demonstrated from the microscopic, synaptic level to the macroscopic, system level. Augmentation of compensatory mechanisms, in addition to ameliorating the loss of dopaminergic neurons, may represent a joint strategy for overall minimization of disability.
引用
收藏
页码:407 / 412
页数:6
相关论文
共 52 条
[1]   [C-11] RACLOPRIDE AND POSITRON EMISSION TOMOGRAPHY IN PREVIOUSLY UNTREATED PATIENTS WITH PARKINSONS-DISEASE - INFLUENCE OF L-DOPA AND LISURIDE THERAPY ON STRIATAL DOPAMINE D-2-RECEPTORS [J].
ANTONINI, A ;
SCHWARZ, J ;
OERTEL, WH ;
BEER, HF ;
MADEJA, UD ;
LEENDERS, KL .
NEUROLOGY, 1994, 44 (07) :1325-1329
[2]   Network modulation in the treatment of Parkinson's disease [J].
Asanuma, Kotaro ;
Tang, Chengke ;
Ma, Yilong ;
Dhawan, Vijay ;
Mattis, Paul ;
Edwards, Christine ;
Kaplitt, Michael G. ;
Feigin, Andrew ;
Eidelberg, David .
BRAIN, 2006, 129 :2667-2678
[3]   Elevated serotonin transporter binding in depressed patients with Parkinson's disease:: A preliminary PET study with [11C]DASB [J].
Boileau, Isabelle ;
Warsh, Jerry J. ;
Guttman, Mark ;
Saint-Cyr, Jean A. ;
McCluskey, Tina ;
Rusjan, Pablo ;
Houle, Sylvain ;
Wilson, Alan A. ;
Meyer, Jeffrey H. ;
Kish, Stephen J. .
MOVEMENT DISORDERS, 2008, 23 (12) :1776-1780
[4]   Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-()-PHNO in drug-nave Parkinsons disease [J].
Boileau, Isabelle ;
Guttman, Mark ;
Rusjan, Pablo ;
Adams, John R. ;
Houle, Sylvain ;
Tong, Junchao ;
Hornykiewicz, Oleh ;
Furukawa, Yoshiaki ;
Wilson, Alan A. ;
Kapur, Shitij ;
Kish, Stephen J. .
BRAIN, 2009, 132 :1366-1375
[5]   Subcortical elevation of metabolism in Parkinson's disease - A critical reappraisal in the context of global mean normalization [J].
Borghammer, Per ;
Cumming, Paul ;
Aanerud, Joel ;
Foerster, Stefan ;
Gjedde, Albert .
NEUROIMAGE, 2009, 47 (04) :1514-1521
[6]   Artefactual subcortical hyperperfusion in PET studies normalized to global mean: Lessons from Parkinson's disease [J].
Borghammer, Per ;
Cumming, Paul ;
Aanerud, Joel ;
Gjedde, Albert .
NEUROIMAGE, 2009, 45 (02) :249-257
[7]   A PET study of sequential finger movements of varying length in patients with Parkinson's disease [J].
Catalan, MJ ;
Ishii, K ;
Honda, M ;
Samii, A ;
Hallett, M .
BRAIN, 1999, 122 :483-495
[8]   Functional changes in the activity of cerebellum and frontostriatal regions during externally and internally timed movement in Parkinson's disease [J].
Cerasa, Antonio ;
Hagberg, Gisela E. ;
Peppe, Antonella ;
Bianciardi, Marta ;
Gioia, M. Cecilia ;
Costa, Alberto ;
Castriota-Scanderbeg, Alessandro ;
Caltagirone, Carlo ;
Sabatini, Umberto .
BRAIN RESEARCH BULLETIN, 2006, 71 (1-3) :259-269
[9]   The role of the striatum and hippocampus in planning - A PET activation study in Parkinson's disease [J].
Dagher, A ;
Owen, AM ;
Boecker, H ;
Brooks, DJ .
BRAIN, 2001, 124 :1020-1032
[10]   Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease:: implications for dyskinesias [J].
de la Fuente-Fernández, R ;
Sossi, V ;
Huang, ZG ;
Furtado, S ;
Lu, JQ ;
Calne, DB ;
Ruth, TJ ;
Stoessl, AJ .
BRAIN, 2004, 127 :2747-2754